Novavax (NVAX) COVID Jab Gets Philippines Nod, Under Review in EU

Novavax’s (NVAX) secures approval for its COVID vaccine in the Philippines. The EMA begins reviewing the company’s regulatory submission for its COVID vaccine. Evidently, the stock gains.